Elevance Health/$ELV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Elevance Health
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Ticker
$ELV
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
104,200
ISIN
US0367521038
Website
Elevance Health Metrics
BasicAdvanced
$85B
14.68
$25.60
0.78
$6.60
1.82%
Price and volume
Market cap
$85B
Beta
0.78
52-week high
$556.17
52-week low
$357.45
Average daily volume
1.8M
Dividend rate
$6.60
Financial strength
Current ratio
1.431
Quick ratio
1.308
Long term debt to equity
65.955
Total debt to equity
70.397
Dividend payout ratio (TTM)
25.60%
Interest coverage (TTM)
7.23%
Profitability
EBITDA (TTM)
9,787
Gross margin (TTM)
27.74%
Net profit margin (TTM)
3.23%
Operating margin (TTM)
4.99%
Effective tax rate (TTM)
23.91%
Revenue per employee (TTM)
$1,760,000
Management effectiveness
Return on assets (TTM)
4.93%
Return on equity (TTM)
14.17%
Valuation
Price to earnings (TTM)
14.682
Price to revenue (TTM)
0.472
Price to book
2
Price to tangible book (TTM)
39.58
Price to free cash flow (TTM)
23.546
Free cash flow yield (TTM)
4.25%
Free cash flow per share (TTM)
1,596.52%
Dividend yield (TTM)
1.76%
Forward dividend yield
1.82%
Growth
Revenue change (TTM)
6.63%
Earnings per share change (TTM)
-3.21%
3-year revenue growth (CAGR)
8.25%
10-year revenue growth (CAGR)
9.33%
3-year earnings per share growth (CAGR)
0.36%
10-year earnings per share growth (CAGR)
10.23%
3-year dividend per share growth (CAGR)
12.22%
10-year dividend per share growth (CAGR)
13.04%
What the Analysts think about Elevance Health
Analyst ratings (Buy, Hold, Sell) for Elevance Health stock.
Bulls say / Bears say
Elevance Health reported adjusted earnings per share of $11.97 for Q1 2025, surpassing analyst expectations of $11.38, indicating strong financial performance. (TradingView News)
The company achieved a 15.4% year-over-year revenue increase to $48.77 billion in Q1 2025, driven by higher premium revenue and growth in its CarelonRx segment. (TradingView News)
Elevance Health has raised its dividend for 14 consecutive years, demonstrating a consistent commitment to returning value to shareholders. (Investing.com)
Elevance Health lowered its full-year adjusted earnings forecast to approximately $33 per share, down from the prior guidance of $37.20, due to higher-than-expected medical expenses. (Seeking Alpha)
The company's Q3 2024 earnings per share decreased by 6.9% year-over-year to $8.37, missing analyst expectations and reflecting increased costs in its Medicaid business. (Kiplinger)
Elevance Health's stock has experienced a significant decline, trading near its 52-week low, which may indicate investor concerns about the company's financial outlook. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 22 May 2025.
Elevance Health Financial Performance
Revenues and expenses
Elevance Health Earnings Performance
Company profitability
Elevance Health News
AllArticlesVideos
ELV COURT REMINDER: Elevance Health, Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by July 11 Court Deadline (NYSE:ELV)
GlobeNewsWire·1 hour ago
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV
GlobeNewsWire·17 hours ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
GlobeNewsWire·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
Jun25
Elevance Health
Dividend·Payment
$1.71Per share
FAQs
What’s the current market cap for Elevance Health stock?
Elevance Health (ELV) has a market cap of $85B as of June 20, 2025.
What is the P/E ratio for Elevance Health stock?
The price to earnings (P/E) ratio for Elevance Health (ELV) stock is 14.68 as of June 20, 2025.
Does Elevance Health stock pay dividends?
Yes, the Elevance Health (ELV) stock pays dividends to shareholders. As of June 20, 2025, the dividend rate is $6.6 and the yield is 1.82%. Elevance Health has a payout ratio of 25.6% on a trailing twelve-month basis.
When is the next Elevance Health dividend payment date?
The next Elevance Health (ELV) dividend payment is scheduled for June 25, 2025.
What is the beta indicator for Elevance Health?
Elevance Health (ELV) has a beta rating of 0.78. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.